Hara Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$116K Hold
1,910
0.06% 144
2025
Q4
$103K Sell
1,910
-200
-9% -$9.62K 0.06% 147
2025
Q3
$95.2K Sell
2,110
-451
-18% -$21.1K 0.06% 145
2025
Q2
$119K Sell
2,561
-5,806
-69% -$285K 0.07% 150
2025
Q1
$510K Sell
8,367
-12,295
-60% -$717K 0.34% 69
2024
Q4
$1.17M Buy
20,662
+10,001
+94% +$559K 0.37% 67
2024
Q3
$552K Sell
10,661
-695
-6% -$32.6K 0.34% 71
2024
Q2
$472K Sell
11,356
-26
-0.2% -$1.16K 0.3% 83
2024
Q1
$617K Sell
11,382
-145
-1% -$7.39K 0.37% 59
2023
Q4
$591K Buy
+11,527
New +$605K 0.42% 51

Other funds holding BMY

Hara Capital's BMY Position: Q1 2026 in Review

Hara Capital held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 1,910 shares worth $116K. The position accounts for 0.06% of the portfolio, ranked #144.

Hara Capital first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.17M in Q4 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hara Capital held 1,910 shares of Bristol-Myers Squibb worth $116K as of Q1 2026.
  • Hara Capital left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.06% of Hara Capital's portfolio in Q1 2026, its #144 holding.
  • Hara Capital first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • Hara Capital's Bristol-Myers Squibb position peaked at $1.17M in Q4 2024.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.